New Pill for Late-Stage Hepatitis C Cures 95 Percent

New Pill for Late-Stage Hepatitis C Cures 95 Percent
Investigators reported encouraging findings at the International Liver Congress in Vienna this month from three phase 3 clinical trials of a new drug combination, grazoprevir and elbasvir, to treat people with chronic hepatitis C infection. Cure rates …
Read more here.

Gilead Profit Soars on Hepatitis C Drugs Sales
The drugs represent two of the most successful drug launches ever, marked by their high cure rates, fewer side effects and imposing price tags; however, they also face increasing competition from new hepatitis C treatments like AbbVie Inc.'s Viekira …
Read more here.

Man Gets Free Hep C Treatment
ALTOONA – A large drug company is now giving free medicine to a local man, denied treatment for a deadly disease. Mike Miller, from Bedford County, is one of more than 100 patients in our region and millions in the United States with hepatitis C, a …
Read more here.

Merck Says Experimental Hepatitis C Treatment Shows 95% Cure Rate
Its study showed an 86% effective rate in pretransplant patients, and a 96% cure rate in post-transplant noncirrhotic patients with recurrent hepatitis C. Harvoni treats genotype 1 while Sovaldi treats genotypes 1 through 4. The two drugs represented …
Read more here.

Need for Speed Defines Hepatitis C Race for Gilead, Achillion
“Hepatitis C has a complicated patient population,” Stefan Zeuzem, a liver disease specialist in Frankfurt who consults for drugmakers developing hepatitis treatments, said in an interview at a liver disease conference in Vienna. “The more advanced the …
Read more here.

When a short course of sofosbuvir/ledipasvir fails, some people can be cured
More than 70% of people with chronic genotype 1 hepatitis C who did not achieve a sustained virological response when treated with sofosbuvir/ledipasvir (Harvoni) for 8 or 12 weeks were cured with a subsequent 24-week course of the same two drugs, …
Read more here.

New EASL guidelines prioritise interferon-free hepatitis C treatment
The European Association for the Study of the Liver (EASL) released its latest hepatitis C treatment guidelines at the 50th International Liver Congress which took place last week in Vienna, Austria. The guidelines recommend a variety of interferon …
Read more here.

Study results promising for hepatitis C patients awaiting or completing liver
A number of new, highly effective oral treatments for various types of hepatitis C have been approved in the past few years. However, two groups who have not benefitted from the new treatments are patients with hepatitis C who have advanced liver …
Read more here.


Leave a Reply